- Home
- ASRV vs OTLK Comparison
ASRV vs OTLK Comparison
Compare ASRV & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- OTLK
- Stock Information
- Founded
- ASRV 1983
- OTLK 2010
- Country
- ASRV United States
- OTLK United States
- Employees
- ASRV N/A
- OTLK N/A
- Industry
- ASRV Major Banks
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASRV Finance
- OTLK Health Care
- Exchange
- ASRV Nasdaq
- OTLK Nasdaq
- Market Cap
- ASRV 48.4M
- OTLK 48.3M
- IPO Year
- ASRV N/A
- OTLK 2016
- Fundamental
- Price
- ASRV $3.12
- OTLK $2.03
- Analyst Decision
- ASRV
- OTLK Strong Buy
- Analyst Count
- ASRV 0
- OTLK 5
- Target Price
- ASRV N/A
- OTLK $9.60
- AVG Volume (30 Days)
- ASRV 39.2K
- OTLK 853.0K
- Earning Date
- ASRV 07-22-2025
- OTLK 08-13-2025
- Dividend Yield
- ASRV 3.76%
- OTLK N/A
- EPS Growth
- ASRV N/A
- OTLK N/A
- EPS
- ASRV 0.22
- OTLK 0.83
- Revenue
- ASRV $53,037,000.00
- OTLK N/A
- Revenue This Year
- ASRV N/A
- OTLK N/A
- Revenue Next Year
- ASRV N/A
- OTLK $419.06
- P/E Ratio
- ASRV $15.19
- OTLK $2.50
- Revenue Growth
- ASRV 16.87
- OTLK N/A
- 52 Week Low
- ASRV $2.03
- OTLK $0.87
- 52 Week High
- ASRV $3.42
- OTLK $9.25
- Technical
- Relative Strength Index (RSI)
- ASRV 75.87
- OTLK 66.41
- Support Level
- ASRV $2.94
- OTLK $1.56
- Resistance Level
- ASRV $3.42
- OTLK $2.00
- Average True Range (ATR)
- ASRV 0.10
- OTLK 0.13
- MACD
- ASRV 0.02
- OTLK 0.03
- Stochastic Oscillator
- ASRV 77.97
- OTLK 95.88
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.